| Heiko Weert De Riese, MD | |
|
703 S Americana Blvd Ste 150, Boise, ID 83702-4976 | |
| (208) 706-6375 | |
| Not Available |
| Full Name | Heiko Weert De Riese |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 703 S Americana Blvd Ste 150, Boise, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831621333 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 10964340-1205 (Utah) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | M-16773 (Idaho) | Primary |
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
Research to Prevent Blindness, a New York-based foundation, has announced that University of Utah researcher Wolfgang Baehr, Ph.D., will receive the Nelson Trust Award for Retinitis Pigmentosa-and an accompanying $100,000 to pursue new scientific leads to understand contributors to blindness.
Four new genes have been added to the growing list of those known to cause increased breast cancer risk when mutated through the efforts of researchers at Huntsman Cancer Institute (HCI) at the University of Utah, who lead an international consortium working to find more gene mutations that cause inherited breast cancer susceptibilities.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heiko Weert De Riese, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Heiko Weert De Riese, MD 703 S Americana Blvd Ste 150, Boise, ID 83702-4976 Ph: (208) 706-6375 |
News Archive
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
Research to Prevent Blindness, a New York-based foundation, has announced that University of Utah researcher Wolfgang Baehr, Ph.D., will receive the Nelson Trust Award for Retinitis Pigmentosa-and an accompanying $100,000 to pursue new scientific leads to understand contributors to blindness.
Four new genes have been added to the growing list of those known to cause increased breast cancer risk when mutated through the efforts of researchers at Huntsman Cancer Institute (HCI) at the University of Utah, who lead an international consortium working to find more gene mutations that cause inherited breast cancer susceptibilities.
› Verified 5 days ago
Dr. Michael E. Estess, M. D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1471 Shoreline Dr, Suite 119, Boise, ID 83702 Phone: 208-345-2630 Fax: 208-345-6504 | |
John Carr, PMHNP Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1000 N Curtis Rd Ste 202, Boise, ID 83706 Phone: 208-283-7314 | |
Eric A Simmons, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 335 Allumbaugh St, Boise, ID 83704 Phone: 208-376-1611 Fax: 208-658-1753 | |
Dr. Gary Falk, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise Vamc, Boise, ID 83702 Phone: 208-422-1108 | |
Karen Porth, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1072 N Liberty Street, Ste 303, Boise, ID 83704 Phone: 208-367-2800 Fax: 208-367-7111 | |
Ramon R Quijano, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 W Fort St., Fl 2, Boise, ID 83702 Phone: 208-422-1018 | |
Barbara J. Hagen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 413 Allumbaugh St Ste 101, Boise, ID 83704 Phone: 208-323-1125 Fax: 208-323-9604 |